Matteo Marchetti1, Tommaso Vezzaro1, Massimo Carollo2

  • 1Department of Gynecology and Obstetrics, Department of Women and Children's Health, University of Padua, Italy.

Gynecologic oncology
|August 2, 2025
PubMed
概括

患有ER损失或L1CAM过度表达的子宫内膜腺癌患者面临更差的结果. 这些分子标记物,以及ARID1A突变,可以完善无特异分子谱 (NSMP) 亚组的预后.